Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Trygg Pharma Buys U.K. Factory

by Alex Scott
July 23, 2012 | A version of this story appeared in Volume 90, Issue 30

Trygg Pharma, a Norwegian producer of omega-3 concentrates for food and pharmaceutical applications, has acquired a facility in Seal Sands, England, from the drugmaker Lundbeck for $20 million. The facility has been mothballed since Lundbeck switched production to other European sites three years ago. Trygg says it plans to restart the plant to produce omega-3 from fish oil. Oslo-based Aker BioMarine and Lindsay Goldberg, a New York City-based private equity firm, jointly own Trygg.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.